Covidien Reports 12-Mo. DEFINITIVE AR Results: Show Higher Technical Success
November 04, 2014 at 13:24 PM EST
Covidien plc (NYSE: COV) today announced 12-month results of the DEFINITIVE AR study, the first randomized study designed to identify ...
